"Neoplasm Proteins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm.
Descriptor ID |
D009363
|
MeSH Number(s) |
D12.776.624
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Neoplasm Proteins".
Below are MeSH descriptors whose meaning is more specific than "Neoplasm Proteins".
This graph shows the total number of publications written about "Neoplasm Proteins" by people in this website by year, and whether "Neoplasm Proteins" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 15 | 7 | 22 |
1995 | 27 | 10 | 37 |
1996 | 40 | 16 | 56 |
1997 | 27 | 16 | 43 |
1998 | 46 | 15 | 61 |
1999 | 42 | 19 | 61 |
2000 | 32 | 29 | 61 |
2001 | 34 | 25 | 59 |
2002 | 47 | 37 | 84 |
2003 | 48 | 40 | 88 |
2004 | 38 | 33 | 71 |
2005 | 41 | 38 | 79 |
2006 | 42 | 18 | 60 |
2007 | 48 | 36 | 84 |
2008 | 20 | 33 | 53 |
2009 | 39 | 26 | 65 |
2010 | 40 | 29 | 69 |
2011 | 47 | 20 | 67 |
2012 | 36 | 32 | 68 |
2013 | 48 | 15 | 63 |
2014 | 44 | 26 | 70 |
2015 | 59 | 15 | 74 |
2016 | 33 | 20 | 53 |
2017 | 33 | 19 | 52 |
2018 | 48 | 17 | 65 |
2019 | 32 | 16 | 48 |
2020 | 36 | 13 | 49 |
2021 | 30 | 16 | 46 |
2022 | 3 | 5 | 8 |
2023 | 0 | 4 | 4 |
2024 | 3 | 3 | 6 |
To return to the timeline,
click here.
Below are the most recent publications written about "Neoplasm Proteins" by people in Profiles.
-
The cancer-associated secretory phenotype: a new frontier in targeted therapeutics. J Clin Invest. 2024 Sep 03; 134(17).
-
Pediatric glioma immune profiling identifies TIM3 as a therapeutic target in BRAF fusion pilocytic astrocytoma. J Clin Invest. 2024 Aug 13; 134(19).
-
First-in-human dose escalation trial to evaluate the clinical safety and efficacy of an anti-MAGEA1 autologous TCR-transgenic T cell therapy in relapsed and refractory solid tumors. J Immunother Cancer. 2024 Jul 22; 12(7).
-
Brd4::Nutm1 fusion gene initiates NUT carcinoma in vivo. Life Sci Alliance. 2024 Jul; 7(7).
-
Profiling the activity of the para-caspase MALT1 in B-cell acute lymphoblastic leukemia for potential targeted therapeutic application. Haematologica. 2024 05 01; 109(5):1348-1358.
-
A GREB1-steroid receptor feedforward mechanism governs differential GREB1 action in endometrial function and endometriosis. Nat Commun. 2024 Mar 02; 15(1):1947.
-
Monoallelic variation in DHX9, the gene encoding the DExH-box helicase DHX9, underlies neurodevelopment disorders and Charcot-Marie-Tooth disease. Am J Hum Genet. 2023 08 03; 110(8):1394-1413.
-
Sarcoma with MGA::NUTM1 fusion: a report of three cases and literature review. Histopathology. 2023 Nov; 83(5):712-721.
-
Autologous T cell therapy for MAGE-A4+ solid cancers in HLA-A*02+ patients: a phase 1 trial. Nat Med. 2023 01; 29(1):104-114.
-
Detection of Gasdermin C-Mediated Cancer Cell Pyroptosis. Methods Mol Biol. 2023; 2641:135-146.